Cytomegalovirus Retinitis
Showing 1 - 25 of 636
Cytomegalovirus Retinitis, Ganciclovir Eye Drops Trial in Tianjin (2% Ganciclovir Eye Drops)
Recruiting
- Cytomegalovirus Retinitis
- Ganciclovir Eye Drops
- 2% Ganciclovir Eye Drops
-
Tianjin, Tianjin, ChinaTianjin Medical University Eye Hospital
Jun 21, 2023
Cytomegalovirus Retinitis, HIV Trial in Chicago (Zidovudine, Acyclovir)
Completed
- Cytomegalovirus Retinitis
- HIV Infections
-
Chicago, Illinois
- +1 more
Oct 26, 2021
Cytomegalovirus Infections, Cytomegalovirus Retinitis, HIV Trial (Cidofovir, Probenecid)
Withdrawn
- Cytomegalovirus Infections
- +2 more
- (no location specified)
Oct 27, 2021
Cytomegalovirus Retinitis, HIV Trial (Foscarnet sodium)
Withdrawn
- Cytomegalovirus Retinitis
- HIV Infections
- Foscarnet sodium
- (no location specified)
Oct 27, 2021
Cytomegalovirus Retinitis Trial in Beijing
Completed
- Cytomegalovirus Retinitis
-
Beijing, Beijing, ChinaBeijing Youan Hospital, Capital Medical University
Jul 20, 2021
Cytomegalovirus Retinitis, HIV Trial in United States (Ganciclovir)
Completed
- Cytomegalovirus Retinitis
- HIV Infections
-
Los Angeles, California
- +5 more
Oct 28, 2021
Cytomegalovirus Retinitis, HIV Trial in United States (Zidovudine, Sargramostim, Ganciclovir)
Completed
- Cytomegalovirus Retinitis
- HIV Infections
- Zidovudine
- +2 more
-
Los Angeles, California
- +3 more
Oct 28, 2021
Cytomegalovirus Retinitis, HIV Trial in Los Angeles, San Francisco, New York (Foscarnet sodium)
Completed
- Cytomegalovirus Retinitis
- HIV Infections
- Foscarnet sodium
-
Los Angeles, California
- +4 more
Oct 27, 2021
Cytomegalovirus Retinitis, HIV Trial in United States (Foscarnet sodium, Ganciclovir)
Completed
- Cytomegalovirus Retinitis
- HIV Infections
- Foscarnet sodium
- Ganciclovir
-
Los Angeles, California
- +5 more
Oct 28, 2021
Cytomegalovirus Retinitis, HIV Trial in San Diego, San Francisco, New York (Ganciclovir)
Completed
- Cytomegalovirus Retinitis
- HIV Infections
-
San Diego, California
- +4 more
Oct 26, 2021
Cytomegalovirus Retinitis, HIV Trial in United States (Sevirumab, Foscarnet sodium, Ganciclovir)
Completed
- Cytomegalovirus Retinitis
- HIV Infections
- Sevirumab
- +2 more
-
Birmingham, Alabama
- +19 more
Oct 28, 2021
Cytomegalovirus Retinitis, HIV Trial in United States (Foscarnet sodium)
Completed
- Cytomegalovirus Retinitis
- HIV Infections
- Foscarnet sodium
-
Los Angeles, California
- +10 more
Oct 26, 2021
Cytomegalovirus Retinitis, HIV, Gastrointestinal Diseases Trial in United States (Ganciclovir)
Completed
- Cytomegalovirus Retinitis
- +2 more
-
San Francisco, California
- +16 more
Oct 28, 2021
Among AIDS Patients on Cytomegalovirus Retinitis
Completed
- AIDS
-
Baltimore, MarylandJohns Hopkins University
Mar 4, 2021
Adenovirus, Cytomegalovirus Infections, Epstein-Barr Virus Infections Trial in Pittsburgh (Specific T- Lymphocytes)
Not yet recruiting
- Adenovirus
- +2 more
- Specific T- Lymphocytes
-
Pittsburgh, PennsylvaniaUPMC Children's Hospital of Pittsburgh
Sep 8, 2023
Cytomegalovirus Infections, HIV Trial in Puerto Rico, United States (Valganciclovir)
Completed
- Cytomegalovirus Infections
- HIV Infections
-
Birmingham, Alabama
- +56 more
Oct 28, 2021
Congenital Cmv Trial in London
Recruiting
- Congenital Cmv
-
London, United KingdomSt George's University of London
May 2, 2023
Allogeneic Stem Cell Transplant, Viral Infection, Viral Reactivation Trial in Cincinnati (Viral specific VST Infusion)
Recruiting
- Allogeneic Stem Cell Transplant
- +2 more
- Viral specific VST Infusion
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Aug 15, 2022
Understudied Drugs Administered to Children Per Standard of Care
Completed
- Adenovirus
- +58 more
- The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:
-
Anchorage, Alaska
- +51 more
Dec 18, 2019
Viral Infection, Viral Reactivation, Infection in an Immunocompromised Host Trial in Cincinnati (Viral Specific VST Infusion)
Recruiting
- Viral Infection
- +2 more
- Viral Specific VST Infusion
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Apr 7, 2022
Retinitis Pigmentosa Trial in Shanghai (AuTNA I)
Recruiting
- Retinitis Pigmentosa
- AuTNA I
-
Shanghai, Shanghai, ChinaChunhui Jiang
May 2, 2023
Japanese Participants With X-linked Retinitis Pigmentosa
Recruiting
- X-Linked Retinitis Pigmentosa
-
Tokyo, JapanNational Hospital Organization Tokyo Medical Center
Jan 3, 2023